L Moses Dihydrochloride is a potent, selective, and cell-active PCAF bromodomain (Brd) inhibitor.
in vivo
L-Moses (L-45) shows no observable cytotoxicity in peripheral blood mononuclear cells (PBMC), good cell-permeability, and metabolic stability in human and mouse liver microsomes, supporting its potential for in vivo use[1].
